Protara Therapeutics
NASDAQ: TARA1 known investors
Protara Therapeutics is a clinical-stage biopharmaceutical company developing investigational therapies, including a cell therapy for non-muscle invasive bladder cancer and lymphatic malformations, and an IV choline replacement therapy for patients on parenteral support.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Protara Therapeutics do?
- Protara Therapeutics is a clinical-stage biopharmaceutical company developing investigational therapies, including a cell therapy for non-muscle invasive bladder cancer and lymphatic malformations, and an IV choline replacement therapy for patients on parenteral support.
- Who are Protara Therapeutics's investors?
- Protara Therapeutics's investors include Catalio Capital Management, LP.